18F-Choline PET/CT in Leptomeningeal Breast Cancer Metastases

Lea Cuppari; Pasquale Reccia; Marta Burei; Anna Rita Cervino; Laura Evangelista

doi:10.1097/RLU.0000000000002407

18F-Choline PET/CT in Leptomeningeal Breast Cancer Metastases

Lea Cuppari, Pasquale Reccia, Marta Burei, Anna Rita Cervino, Laura Evangelista

Istituto Oncologico Veneto

Research output: Contribution to journal › Article

Abstract

We describe a case of 47-year-old woman affected by human epidermal growth factor receptor-2-positive breast cancer with a diffuse leptomeningeal carcinomatosis. An intense uptake of F-choline was reported at fused PET/MRI images in the brain, compatible with a diffuse leptomeningeal disease. This case highlights that F-choline PET would be used for the identification of leptomeningeal involvement in patients affected by breast cancer, as a support of MRI images.

Original language	English
Pages (from-to)	e96-e97
Journal	Clinical Nuclear Medicine
Volume	44
Issue number	2
DOIs	https://doi.org/10.1097/RLU.0000000000002407
Publication status	Published - Feb 2019

Access to Document

10.1097/RLU.0000000000002407

Fingerprint Dive into the research topics of '18F-Choline PET/CT in Leptomeningeal Breast Cancer Metastases'. Together they form a unique fingerprint.

Cite this

Cuppari, L., Reccia, P., Burei, M., Cervino, A. R., & Evangelista, L. (2019). 18F-Choline PET/CT in Leptomeningeal Breast Cancer Metastases. Clinical Nuclear Medicine, 44(2), e96-e97. https://doi.org/10.1097/RLU.0000000000002407

@article{4cf193c18bba4bf587aec677215734ea,

title = "18F-Choline PET/CT in Leptomeningeal Breast Cancer Metastases",

abstract = "We describe a case of 47-year-old woman affected by human epidermal growth factor receptor-2-positive breast cancer with a diffuse leptomeningeal carcinomatosis. An intense uptake of F-choline was reported at fused PET/MRI images in the brain, compatible with a diffuse leptomeningeal disease. This case highlights that F-choline PET would be used for the identification of leptomeningeal involvement in patients affected by breast cancer, as a support of MRI images.",

author = "Lea Cuppari and Pasquale Reccia and Marta Burei and Cervino, {Anna Rita} and Laura Evangelista",

year = "2019",

month = feb,

doi = "10.1097/RLU.0000000000002407",

language = "English",

volume = "44",

pages = "e96--e97",

journal = "Clinical Nuclear Medicine",

issn = "0363-9762",

publisher = "Lippincott Williams and Wilkins",

number = "2",

}

TY - JOUR

T1 - 18F-Choline PET/CT in Leptomeningeal Breast Cancer Metastases

AU - Cuppari, Lea

AU - Reccia, Pasquale

AU - Burei, Marta

AU - Cervino, Anna Rita

AU - Evangelista, Laura

PY - 2019/2

Y1 - 2019/2

N2 - We describe a case of 47-year-old woman affected by human epidermal growth factor receptor-2-positive breast cancer with a diffuse leptomeningeal carcinomatosis. An intense uptake of F-choline was reported at fused PET/MRI images in the brain, compatible with a diffuse leptomeningeal disease. This case highlights that F-choline PET would be used for the identification of leptomeningeal involvement in patients affected by breast cancer, as a support of MRI images.

AB - We describe a case of 47-year-old woman affected by human epidermal growth factor receptor-2-positive breast cancer with a diffuse leptomeningeal carcinomatosis. An intense uptake of F-choline was reported at fused PET/MRI images in the brain, compatible with a diffuse leptomeningeal disease. This case highlights that F-choline PET would be used for the identification of leptomeningeal involvement in patients affected by breast cancer, as a support of MRI images.

U2 - 10.1097/RLU.0000000000002407

DO - 10.1097/RLU.0000000000002407

M3 - Article

C2 - 30516668

VL - 44

SP - e96-e97

JO - Clinical Nuclear Medicine

JF - Clinical Nuclear Medicine

SN - 0363-9762

IS - 2

ER -